Tags

Type your tag names separated by a space and hit enter

Lyme Neuroborreliosis.
Continuum (Minneap Minn). 2015 Dec; 21(6 Neuroinfectious Disease):1729-44.C

Abstract

PURPOSE OF REVIEW

Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common tick-borne illness in the United States and Europe. Lyme disease usually begins with the characteristic skin lesion, erythema migrans, at the site of the tick bite. Following hematogenous dissemination, neurologic, cardiac, and/or rheumatologic involvement may occur. Neurologic involvement occurs in up to 15% of untreated B. burgdorferi infection and neurologists should be familiar with its diagnosis and management.

RECENT FINDINGS

The most common early neurologic manifestations of Lyme disease are cranial neuropathy (particularly facial palsy), lymphocytic meningitis, and radiculoneuritis, which often occur in combination. Late neuroborreliosis occurs much less frequently than early disease. A combination of clinical and laboratory findings is recommended for the diagnosis of Lyme neuroborreliosis. Treatment with recommended antibiotic regimens is effective in Lyme neuroborreliosis, and patients with early disease usually have excellent outcomes. Recovery is slower and may be incomplete in patients with late disease.

SUMMARY

Nervous system involvement occurs in up to 15% of patients with untreated B. burgdorferi infection. This article reviews clinical aspects of the diagnosis and treatment of Lyme neuroborreliosis, with focus on the United States.

Authors

No affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Intramural
Review

Language

eng

PubMed ID

26633786

Citation

Marques, Adriana R.. "Lyme Neuroborreliosis." Continuum (Minneapolis, Minn.), vol. 21, no. 6 Neuroinfectious Disease, 2015, pp. 1729-44.
Marques AR. Lyme Neuroborreliosis. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1729-44.
Marques, A. R. (2015). Lyme Neuroborreliosis. Continuum (Minneapolis, Minn.), 21(6 Neuroinfectious Disease), 1729-44. https://doi.org/10.1212/CON.0000000000000252
Marques AR. Lyme Neuroborreliosis. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1729-44. PubMed PMID: 26633786.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Lyme Neuroborreliosis. A1 - Marques,Adriana R, PY - 2015/12/4/entrez PY - 2015/12/4/pubmed PY - 2016/9/16/medline SP - 1729 EP - 44 JF - Continuum (Minneapolis, Minn.) JO - Continuum (Minneap Minn) VL - 21 IS - 6 Neuroinfectious Disease N2 - PURPOSE OF REVIEW: Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common tick-borne illness in the United States and Europe. Lyme disease usually begins with the characteristic skin lesion, erythema migrans, at the site of the tick bite. Following hematogenous dissemination, neurologic, cardiac, and/or rheumatologic involvement may occur. Neurologic involvement occurs in up to 15% of untreated B. burgdorferi infection and neurologists should be familiar with its diagnosis and management. RECENT FINDINGS: The most common early neurologic manifestations of Lyme disease are cranial neuropathy (particularly facial palsy), lymphocytic meningitis, and radiculoneuritis, which often occur in combination. Late neuroborreliosis occurs much less frequently than early disease. A combination of clinical and laboratory findings is recommended for the diagnosis of Lyme neuroborreliosis. Treatment with recommended antibiotic regimens is effective in Lyme neuroborreliosis, and patients with early disease usually have excellent outcomes. Recovery is slower and may be incomplete in patients with late disease. SUMMARY: Nervous system involvement occurs in up to 15% of patients with untreated B. burgdorferi infection. This article reviews clinical aspects of the diagnosis and treatment of Lyme neuroborreliosis, with focus on the United States. SN - 1538-6899 UR - https://www.unboundmedicine.com/medline/citation/26633786/Lyme_Neuroborreliosis_ L2 - http://dx.doi.org/10.1212/CON.0000000000000252 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.